How to Choose the Right HbA1c Machine for Your Clinic in India

India has over 101 million adults living with diabetes according to the ICMR-INDIAB study (2023). Most of them live in small towns and villages — far from the referral labs that currently run HbA1c testing. If you're a clinic owner, PHC doctor, or procurement officer trying to add HbA1c to your test menu, you've probably already run into the confusion: five brands, five different price points, and no str

aightforward comparison.

 Here's one.

What Is an HbA1c Machine?

An HbA1c machine measures glycated hemoglobin—a marker that reflects average blood sugar levels over the past two to three months. Unlike a fasting glucose test that shows a single snapshot, HbA1c tells the fuller story of a patient's diabetes control. It's the reference standard for both diagnosis and long-term monitoring, recommended by both the American Diabetes Association and ICMR guidelines.

Machines vary by technology, price, portability, and—critically—what else they can test alongside HbA1c. Before the brand-by-brand breakdown, it helps to understand the three technologies used across every device on the Indian market today.

 How HbA1c Machines Actually Work: Three Technologies

 HPLC (High-Performance Liquid Chromatography)

The reference method used in large diagnostic labs. Extremely accurate, it handles Indian hemoglobin variants (HbE, HbD, and HbS) well and remains the standard for confirmatory testing. Requires benchtop hardware, mains power, trained operators, and higher consumable costs. Best suited to referral labs running high daily volumes.

Boronate Affinity.

A chemistry-based method used in most point-of-care and cartridge/strip devices. Faster and cheaper than HPLC and reasonably accurate for routine monitoring in stable, non-variant populations. Susceptible to interference from certain hemoglobin variants without correction.

 Fluoroimmunoassay (FIA)

Uses fluorescent labels to detect glycated hemoglobin. Works well in multi-parameter devices—HbA1c can share a platform with other analytes like thyroid, cardiac markers, and vitamins. Result times vary by cartridge.

Which technology matters most for you depends on your setting: a high-volume urban lab benefits from HPLC's precision; a rural PHC needs the flexibility of a multi-parameter platform.

Why Mobilab Is Different

Every device above solves one problem: HbA1c. But a patient walking into a PHC in rural Odisha, Rajasthan, or Assam rarely has just one problem. She has diabetes and anemia and kidney stress and a liver that's been quietly struggling. Running four separate machines — even if you could afford them all — isn't realistic.

Mobilab is India's first AI-powered portable diagnostic platform. A full clinical panel—HbA1c, CBC, LFT, KFT, lipid profile, glucose, and more—from a single venous blood sample, delivered in about 30 minutes, on battery power, at the point of care.

What that means, concretely:

•  A complete panel from one venous blood draw—HbA1c alongside CBC (for anaemia), LFT, KFT, Lipid Profile, and Glucose in a single run

•  30 minutes to full-panel result—same visit, same conversation, same patient

•  Battery-operated with full-day runtime—works where mains power doesn't

•  Jointly assessed and actively supported by ICMR and AIIMS Delhi—not just tested, actively backed by two of India's most senior medical bodies

• More than 92% accuracy against reference laboratory methods in ICMR's assessment

•  Additional multi-site validation at GMCH, GNRC, Nemcare, and the Indian Army

•  CDSCO Licensed (MFG/IVD/2025/000042). ISO 13485:2016 and ISO 9001:2015 certified

•  300,000+ tests conducted across 15+ Indian states—and now expanding globally

For a PHC serving ~40 patients a day, replacing four devices with one—and eliminating three separate consumable supply chains—changes the operating economics of the entire clinic.

 ---

Buy Mobilab if you're deploying in a PHC, CHC, health camp, corporate wellness site, or NGO program—anywhere your patients need more than one test, mains power is unreliable, and your procurement scoring rewards institutional validation.

Frequently Asked Questions

Q1. What's the difference between HPLC and boronate affinity for HbA1c testing?

HPLC is the reference method—used in large labs, most accurate, and handles hemoglobin variants better. Boronate affinity is the chemistry-based method used in most point-of-care and strip devices — faster and cheaper, and suitable for routine monitoring in stable populations.

Q2. Is a portable HbA1c device as accurate as a lab HPLC?

For routine monitoring in populations without significant hemoglobin variants, well-validated portable devices produce clinically comparable results. For confirmatory testing or in patients with variant hemoglobin, HPLC remains the standard. Mobilab has been assessed against reference laboratory methods by ICMR at more than 92% concordance.

Q3. Can I claim NHM procurement or a government tender for a portable device?

Yes—provided the device carries a valid CDSCO manufacturing license and ISO 13485:2016 certification and the tender specification permits portable/point-of-care equipment. Institutional validation from ICMR or AIIMS strengthens the bid.

Q4. What's the typical cost per HbA1c test in India?

 It ranges from around ₹16 (Erba HPLC at high volume) to ₹350 (Finecare cartridge) for reagent cost alone. Volume, service costs, and whether your device also runs other parameters materially change the operating cost per patient.

Q5. Does Mobilab replace a full lab setup?

For the panel it covers—HbA1c, CBC, LFT, KFT, Lipid Profile, Glucose, and more from a single venous blood draw—Mobilab delivers the same tests you'd send to a reference lab, at the point of care in 30 minutes. It's designed for settings where a full lab isn't practical.

How do I request a demo?

Call +91 93957 14393 or visit mobilab.in. Demos are available across India, including at your clinic, hospital, or program site.

Mobilab: India's next-gen AI health tech company. Portable. AI-powered. Jointly assessed and actively supported by ICMR and AIIMS Delhi. Deployed across 15+ Indian states and expanding globally.